Scribd Logo
Upload

Welcome to Scribd!

  • Euglycemic DKA References

    Uploaded by

    Katie Thompson
    14 views1 page
    This article discusses euglycemic diabetic ketoacidosis (EDKA), an uncommon complication in patients taking sodium-glucose co-transporter 2 (SGLT2) inhibitors. EDKA occurs when patients develop ketoacidosis but have normal blood glucose levels. The authors review previous literature on EDKA cases associated with SGLT2 inhibitor use. They discuss how EDKA poses a diagnostic and treatment challenge as patients do not present with typical high blood glucose levels seen in diabetic ketoacidosis. The article concludes by emphasizing the need for awareness of EDKA as a potential safety issue for patients taking SGLT2 inhibitors.

    Original Description:

    References for eKDA Presentation

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This article discusses euglycemic diabetic ketoacidosis (EDKA), an uncommon complication in patients taking sodium-glucose co-transporter 2 (SGLT2) inhibitors. EDKA occurs when patients develop ketoacidosis but have normal blood glucose levels. The authors review previous literature on EDKA cases associated with SGLT2 inhibitor use. They discuss how EDKA poses a diagnostic and treatment challenge as patients do not present with typical high blood glucose levels seen in diabetic ketoacidosis. The article concludes by emphasizing the need for awareness of EDKA as a potential safety issue for patients taking SGLT2 inhibitors.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    14 views1 page

    Euglycemic DKA References

    Uploaded by

    Katie Thompson
    This article discusses euglycemic diabetic ketoacidosis (EDKA), an uncommon complication in patients taking sodium-glucose co-transporter 2 (SGLT2) inhibitors. EDKA occurs when patients develop ketoacidosis but have normal blood glucose levels. The authors review previous literature on EDKA cases associated with SGLT2 inhibitor use. They discuss how EDKA poses a diagnostic and treatment challenge as patients do not present with typical high blood glucose levels seen in diabetic ketoacidosis. The article concludes by emphasizing the need for awareness of EDKA as a potential safety issue for patients taking SGLT2 inhibitors.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Euglycemic Diabetic Ketoacidosis: An Uncommon Complication in

    Patients Taking Sodium Glucose Co-Transporter 2 Inhibitors


    Katie Thompson, MSN, ACNPC-AG; Richard Schulick, MD, MBA, FACS; Benjamin Scott, MD;
    Zachary Asher, PA-C

    References

    Peters, A.L., Buschur, E.O., Buse, J.B., Cohan, P., Diner, J.C., & Hirsch,
    I.B. (2015). Euglycemic diabetic ketoacidosis: A potential
    complication of treatment with sodium-glucose cotransporter 2
    Inhibition. Diabetes Care, 38(9), 1687-1693.
    https://doi.org/10.2337/dc15-0843

    Plewa, M.C., Bryant, M., & King-Thiele, R. (2021). Euglycemic diabetic


    ketoacidosis. StatPearls. Treasure Island (FL): StatPearls Publishing;
    2021. Available from
    https://www.ncbi.nlm.nih.gov/books/NBK554570/

    Rawla, P., Vellipuram, A.R., Bandaru, S.S., & Raj, J.P. (2017). Euglycemic
    diabetic ketoacidosis: A diagnostic and therapeutic dilemma.
    Endocrinology, Diabetes & Metabolism Case Reports, 2017, 17-0081.
    https://doi.org/10.1530/EDM-17-0081

    Rosenstock, J. & Ferrannini, E. (2015). Euglycemic diabetic ketoacidosis: A


    predictable, detectable, and preventable safety concern with SGLT2
    inhibitors. Diabetes Care, 38(9), 1638-1642.
    https://doi.org/10.2337/dc15-1380

    You might also like